Literature DB >> 26787825

Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator.

Yutaka Kurebayashi1, Katsura Emoto2, Yuichiro Hayashi3, Ikuo Kamiyama4, Takashi Ohtsuka4, Hisao Asamura4, Michiie Sakamoto5.   

Abstract

Neoplastic cancer cells and cancer stroma (including infiltrating immune cells) determine the biology and prognosis of cancer. Various types of adaptive and innate immune cells are known to infiltrate the cancer stroma. However, the patterns and spatial distribution of immune cell infiltration as well as its association with tumor histology remain poorly understood. To address these issues, we comprehensively analyzed the infiltrating immune cells present in lung adenocarcinoma. The principal types of both adaptive and innate infiltrating immune cells were immunohistochemically evaluated in the predominant histologic components of 111 lung adenocarcinomas. The same analysis was also carried out on 143 samples of histologic subtypes making up more than 20% of tumors. As a result, plasma cells and B cells with interfollicular distribution were almost exclusively observed in invasive histologic subtypes, while an increased number of mast cells were observed in noninvasive histologic subtypes. Cluster analysis revealed four distinct immunosubtypes (CD8, mast cell, macrophage/dendritic cell, and plasma cell subtypes) based on the infiltrating immune cell profiles. These immunosubtypes correlated with histologic subtypes, and univariate and multivariate analyses identified the plasma cell subtype as an independent negative prognostic factor. These plasma cells may be one of the major producers of the immunosuppressive cytokine IL35 in cancer stroma. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26787825     DOI: 10.1158/2326-6066.CIR-15-0214

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  39 in total

Review 1.  Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer.

Authors:  Si-Si Wang; Wei Liu; Dalam Ly; Hao Xu; Limei Qu; Li Zhang
Journal:  Cell Mol Immunol       Date:  2018-04-08       Impact factor: 11.530

2.  B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies.

Authors:  Hans A Schlößer; Martin Thelen; Axel Lechner; Kerstin Wennhold; Maria A Garcia-Marquez; Sacha I Rothschild; Elena Staib; Thomas Zander; Dirk Beutner; Birgit Gathof; Ramona Gilles; Engin Cukuroglu; Jonathan Göke; Alexander Shimabukuro-Vornhagen; Uta Drebber; Alexander Quaas; Christiane J Bruns; Arnulf H Hölscher; Michael S Von Bergwelt-Baildon
Journal:  Oncoimmunology       Date:  2018-11-02       Impact factor: 8.110

Review 3.  Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.

Authors:  Geetha Shanmugam; Sumana Das; Sambuddha Paul; Sudeshna Rakshit; Koustav Sarkar
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

4.  Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans.

Authors:  Khadijah A Mitchell; Adriana Zingone; Leila Toulabi; Jacob Boeckelman; Bríd M Ryan
Journal:  Clin Cancer Res       Date:  2017-12-01       Impact factor: 12.531

5.  Methylation Regulation of TLR3 on Immune Parameters in Lung Adenocarcinoma.

Authors:  Ang Li; Hongjiao Wu; Qinqin Tian; Yi Zhang; Zhi Zhang; Xuemei Zhang
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

6.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12

7.  Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma.

Authors:  Chengyun Yao; Hongliang Yu; Guoren Zhou; Jianhua Xu; Dayong Gu; Li Yin; Xia He; Hongping Xia
Journal:  Esophagus       Date:  2021-03-10       Impact factor: 4.230

8.  Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics.

Authors:  Minyi Chen; Franziska Werner; Christine Wagner; Martin Simon; Erika Richtig; Kirsten D Mertz; Johannes Griss; Stephan N Wagner
Journal:  Front Cell Dev Biol       Date:  2021-05-21

9.  Bioinformatics Analysis of GFAP as a Potential Key Regulator in Different Immune Phenotypes of Prostate Cancer.

Authors:  Wencheng Yao; Xiang Li; Zhankui Jia; Chaohui Gu; Zhibo Jin; Jun Wang; Bo Yuan; Jinjian Yang
Journal:  Biomed Res Int       Date:  2021-06-17       Impact factor: 3.411

Review 10.  The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.

Authors:  Nicole J Flynn; Rajasekharan Somasundaram; Kimberly M Arnold; Jennifer Sims-Mourtada
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.